Device
SWE
SWE is a medical device with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
Early Phase 1First-in-human
1(100.0%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
Completed1
Recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 11 (100.0%)
Trials by Status
completed133%
recruiting133%
unknown133%
Recent Activity
1 active trials
Showing 3 of 3
recruiting
Establishment of NAFLD Cohort and Development of Fibrosis Markers
NCT02206841
completedearly_phase_1
Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma
NCT02384473
unknown
The Multi-Center Study of Shear Wave Elastography on Thyroid Nodules
NCT02937467
Clinical Trials (3)
Showing 3 of 3 trials
NCT02206841
Establishment of NAFLD Cohort and Development of Fibrosis Markers
NCT02384473Early Phase 1
Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma
NCT02937467
The Multi-Center Study of Shear Wave Elastography on Thyroid Nodules
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3